Some foods and herbs have small studies of sperm measurements, but a better semen result does not guarantee conception. Several larger supplement trials have not improved pregnancy or birth outcomes. These records compare the evidence rather than rank remedies.
Semen quality, male-factor infertility and reproductive outcomes. Sperm concentration, motility, morphology and DNA measures are distinct from pregnancy and live birth. Testicular emergencies and cancer care remain separate.
Decorative topic illustration.
Care basics come first
Seek evaluation for both partners when conception is delayed; a clinician can advise earlier assessment based on age, history or known concerns.
A semen analysis assesses sperm amount, movement and shape; abnormal results may need a repeat test and specialist assessment.
Discuss smoking, alcohol, weight, workplace exposures and medicines with the care team. Avoid anabolic steroids.
Testosterone treatment can suppress sperm production. Discuss fertility plans before starting it; do not stop prescribed treatment without medical advice.
A balanced diet and correction of a diagnosed deficiency differ from routinely adding high-dose fertility supplements.
How we chose these entries
Selected food, herb, nutrient and combination studies include limited positive findings, important no-benefit results, historical context and a clearly separated laboratory reference.
Evidence does not establish a general fertility supplement regimen. Most small positive studies measure semen rather than pregnancy or live birth. Results do not establish cancer prevention, treatment of torsion, healthy-testis protection or universal testosterone enhancement.
No records match. Try another name or clear the filters.
Care and risk-reduction research
Read the outcome, preparation and limits. A studied benefit does not make every product effective.
Support during care
Black seed oil
Ingredient reference illustration: Black seed oil. Studied form: Cold-pressed seed oil. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.
Nigella sativa L. · Seed fixed oil
Form
Cold-pressed seed oil
How it is used
oral
Evidence
Limited clinical evidence
One small placebo-controlled trial reported better sperm concentration, motility and morphology. Pregnancy and live-birth benefit was not established.
Condition and setting
Abnormal semen quality in men with infertility
Cautions
Study exposure is not a personal dose recommendation. Severe dermatitis has followed topical oil use; the drug-metabolism signal came from oral seed in four volunteers, not a test of every oil product. Ask a pharmacist to review medicines.
Two months; 34 analyzed per arm; 2.5 mL twice daily versus liquid paraffin.
What this does not show
Short trial in selected infertile men; does not show healthy-testis protection or treatment of testicular disease. Essential oil and isolated thymoquinone are different.
Exact ingredient
The trial concerns expressed fixed seed oil; whole seed, essential oil and isolated thymoquinone are different materials.
Why we included it
Direct human semen research distinct from cancer claims.
Related material only
These are different ingredients or forms. Do not assume the same findings apply to them.
Ingredient reference illustration: Black cumin seed (KJV fitches candidate). Studied form: Seed-powder capsules; separate traditional-use context. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.
Nigella sativa L. · Seed
Form
Seed-powder capsules; separate traditional-use context
How it is used
oral
Evidence
Very low-certainty clinical evidence
A weak study reported semen and hormone changes. These findings do not establish a testosterone booster or an infertility treatment.
Condition and setting
Male infertility and reproductive-hormone research
Cautions
Medicinal supplementation differs from a culinary serving. No proven pregnancy/live-birth benefit; do not postpone evaluation.
Reported 2 g/day for three months; 55 enrolled, 40 completed. A separate traditional database records an ejaculation-related use.
What this does not show
Placebo allocation/sample sizes and analysis are unclear. A separate obesity study found no significant free-testosterone advantage; traditional terms do not establish modern diagnoses.
Exact ingredient
The evidence concerns oral seed powder; the pressed fixed oil has separate evidence.
Why we included it
Separates whole-seed evidence and tradition from pressed oil.
Related material only
These are different ingredients or forms. Do not assume the same findings apply to them.
Ingredient reference illustration: Walnuts (Persian / English). Studied form: Whole shelled walnuts added to usual diet. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.
Juglans regia L. · Edible kernel
Form
Whole shelled walnuts added to usual diet
How it is used
oral food
Evidence
Limited dietary trial evidence
Sperm vitality, motility and morphology improved in a dietary trial. This is not evidence of more pregnancies or live births.
Condition and setting
Semen quality in healthy young men eating a Western-style diet
Cautions
Avoid with walnut allergy. Account for the substantial food energy and overall diet; the study portion is not a required fertility prescription.
Supportive-care research reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.
Phoenix dactylifera L.; Nigella sativa L. · Date-palm pollen and black seed preparation
Form
Studied combination capsules plus standard infertility treatment
How it is used
oral
Evidence
Very low-certainty combination evidence
The small combination trial reported sperm and hormone changes, but it cannot identify black seed’s contribution.
Condition and setting
Male infertility; semen and hormone measures
Cautions
Do not recreate the reported capsule regimen or substitute retail oil. Check allergy history and every product ingredient with the care team.
Why no exact ingredient link?
This is a combined date-palm pollen and black-seed preparation with inconsistent ingredient descriptions; neither ingredient alone represents it.
Evidence, limits and sources for Date-palm pollen and black-seed combination
What was found
Single-blind study, 50 analyzed over three months.
What this does not show
Dose and preparation descriptions conflict, including seed versus pollen terminology. No demonstrated live-birth benefit.
Exact ingredient
This is a combined date-palm pollen and black-seed preparation with inconsistent ingredient descriptions; neither ingredient alone represents it.
Why we included it
Keeps a mixed traditional preparation separate from single-herb claims.
Related material only
These are different ingredients or forms. Do not assume the same findings apply to them.
Ingredient reference illustration: Ashwagandha root. Studied form: KSM-66 root extract standardized to at least 5% withanolides. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.
Withania somnifera (L.) Dunal · Root
Form
KSM-66 root extract standardized to at least 5% withanolides
How it is used
oral
Evidence
Limited pilot-trial evidence
A small pilot trial reported improved sperm concentration, motility and semen volume. It did not establish a pregnancy or live-birth benefit.
Condition and setting
Oligospermia in men with infertility
Cautions
Drowsiness and digestive upset can occur; liver injury has been reported. Discuss liver or thyroid disease and medicines with a clinician. Long-term safety is uncertain. Avoid with hormone-sensitive prostate cancer.
Double-blind placebo-controlled trial; 46 men; 675 mg/day of the specified root extract for 90 days.
What this does not show
Exploratory sample without a power calculation. Widely quoted percentage improvements compare the treated group with its own baseline, not with placebo. Findings cannot establish a general fertility or testosterone treatment.
Exact ingredient
The evidence concerns a standardized root-only extract; raw root powder and root-leaf extracts are different preparations.
Why we included it
A directly studied root preparation with preliminary semen findings and important safety limits.
Ingredient reference illustration: Maca. Studied form: Gelatinized maca powder in capsules; yellow maca specified in the 2021 trial. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.
Lepidium meyenii Walp. · Dried underground hypocotyl/root, described as bulb in the yellow-maca trial
Form
Gelatinized maca powder in capsules; yellow maca specified in the 2021 trial
How it is used
oral
Evidence
Mixed, low-certainty clinical evidence
Small placebo-controlled trials give mixed results. One found higher sperm concentration; another did not establish a semen benefit. Improved pregnancy or live birth is unproven.
Condition and setting
Semen quality in men with infertility
Cautions
One trial reported no adverse effects; the other had two withdrawals for possible adverse events, with causality uncertain. Small trials cannot establish long-term safety.
2020: 69 men randomized, 2 g/day for 12 weeks. 2021: 50 randomized, yellow maca 2.8 g/day for 16 weeks.
What this does not show
Small samples, short follow-up and attrition. The positive trial found no benefit in motility, morphology or volume. Four incidental partner pregnancies in the other trial do not establish efficacy.
Exact ingredient
The tested gelatinized powders are not interchangeable with concentrated extracts or an assumed black-maca formulation.
Why we included it
Contrasting randomized results counter a simple fertility-enhancement claim.
Ingredient reference illustration: Omega fatty acid oils. Studied form: Specified EPA/DHA oils, including EPAX 5500TG and DHA-enriched fish triglyceride oil. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.
Eicosapentaenoic acid and docosahexaenoic acid
Form
Specified EPA/DHA oils, including EPAX 5500TG and DHA-enriched fish triglyceride oil
How it is used
oral
Evidence
Mixed surrogate-outcome evidence
Trials give mixed sperm-marker results. An EPA/DHA trial reported improved count and concentration; another improved DNA-fragmentation measures without conventional semen benefits. Pregnancy and live-birth benefit is unproven.
Condition and setting
Semen quality and sperm DNA measures in fertility-clinic populations
Cautions
Fish-oil preparations may cause unpleasant taste, bad breath, heartburn or digestive upset. Discuss anticoagulants and other medicines with a clinician before supplementation.
Evidence, limits and sources for Omega-3 EPA and DHA preparations
What was found
2011: 238 randomized, 211 completed; EPA+DHA 1.84 g/day for 32 weeks. 2016: 74 randomized, 57 analyzed; DHA 990 mg plus EPA 135 mg/day for ten weeks.
What this does not show
Different formulations, attrition and surrogate outcomes limit confidence. The 2011 abstract reports baseline-to-end changes rather than a complete placebo-adjusted estimate. These trials do not test an omega-3/6/9 blend.
Exact ingredient
The findings apply to the specified EPA/DHA oils, not to omega-6/9 blends or assumed equivalent effects of plant ALA.
Why we included it
Distinguishes exact EPA/DHA trial preparations from broader fatty-acid marketing.
These historical reports or laboratory findings do not establish a clinical benefit.
Early lab research
Black-seed aqueous extract: laboratory sperm research
Early lab research. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.
Nigella sativa L. · Seed
Form
Aqueous extract added to cryopreservation medium
How it is used
ex vivo laboratory use
Evidence
Human-sample laboratory evidence
A laboratory experiment reported improvements in selected post-thaw sperm measures. This was not a trial of men swallowing a supplement.
Condition and setting
Human sperm specimens during freezing/thawing
Cautions
Never add household extracts or oils to semen, fertility-treatment media or the genitals based on this experiment.
Why no exact ingredient link?
This aqueous seed extract was added to a laboratory sperm medium; it is not an oral seed or fixed-oil preparation.
Evidence, limits and sources for Black-seed aqueous extract: laboratory sperm research
What was found
Twenty sperm samples tested under controlled vitrification conditions.
What this does not show
No demonstrated conception or birth benefit; laboratory concentration and route cannot be translated into oral or genital use.
Exact ingredient
This aqueous seed extract was added to a laboratory sperm medium; it is not an oral seed or fixed-oil preparation.
Why we included it
Makes the human-sample versus treated-human distinction explicit.
Related material only
These are different ingredients or forms. Do not assume the same findings apply to them.
These records explain what to avoid or why a proposed benefit is not established.
No benefit or possible harm
Saffron extract: unresolved plant-part reporting
No-benefit evidence reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.
Crocus sativus L. · Reported as stigma, but extraction description says petal
Saffron did not significantly improve sperm density, motility, morphology or seminal antioxidant capacity versus placebo.
Condition and setting
Idiopathic oligoasthenoteratozoospermia
Cautions
Four saffron recipients stopped because of adverse events, including nausea, headache, increased appetite and hypomania. Do not increase the dose to overcome a negative result.
Why no exact ingredient link?
The trial methods conflict between stigma and petal extraction, so its material cannot be equated confidently with culinary saffron stigma.
Evidence, limits and sources for Saffron extract: unresolved plant-part reporting
What was found
260 infertile men randomized to 60 mg/day or placebo for 26 weeks.
What this does not show
The methods call purchased material stigma but describe extracting petal. Exact identity is unresolved; do not silently equate this preparation with culinary stigma or crocin.
Exact ingredient
The trial methods conflict between stigma and petal extraction, so its material cannot be equated confidently with culinary saffron stigma.
Why we included it
A meaningful negative result for a traditionally promoted herb.
Related material only
These are different ingredients or forms. Do not assume the same findings apply to them.
No-benefit evidence reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.
Vitamins, minerals, L-carnitine and lycopene
Form
Studied oral antioxidant combination including vitamins C, E and D, selenium, L-carnitine, zinc, folic acid and lycopene
How it is used
oral
Evidence
Negative multicenter randomized pilot
No improvement in semen quality or DNA integrity was established. Live births were 15% versus 24% with placebo, without a significant difference.
Condition and setting
Male-factor infertility; semen and live-birth outcomes
Cautions
Avoid stacking overlapping fertility vitamins. More antioxidants are not automatically better.
Why no exact ingredient link?
This is a multi-ingredient antioxidant formulation; its results cannot be assigned separately to its individual nutrients.
Evidence, limits and sources for MOXI antioxidant combination
What was found
171 participants received assigned supplement/placebo for 3–6 months; couples also had a defined fertility-care pathway.
What this does not show
Early stopping left pregnancy/live-birth analyses underpowered. The lower numerical birth rate is not proof of harm; a blend cannot settle each ingredient’s effects.
Exact ingredient
This is a multi-ingredient antioxidant formulation; its results cannot be assigned separately to its individual nutrients.
Why we included it
Connects laboratory claims with measured birth outcomes.
Related material only
These are different ingredients or forms. Do not assume the same findings apply to them.
No-benefit evidence reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.
Betaine, L-cystine, B vitamins and zinc
Form
Studied Impryl tablet
How it is used
oral
Evidence
Large negative randomized trial
Ongoing pregnancy within six months was not improved: 33.8% versus 37.5% with placebo. This article did not yet report live-birth results.
Condition and setting
Men seeking fertility care; ongoing-pregnancy outcome
Cautions
Reported adverse events were uncommon and similar, including digestive discomfort, fatigue and headache. Routine use was not supported.
Why no exact ingredient link?
This is the tested Impryl combination; individual nutrients and other antioxidant blends are not equivalent treatments.
Evidence, limits and sources for SUMMER antioxidant combination (Impryl)
What was found
2025 multicenter double-blind trial; 1,171 men analyzed, daily combination for six months alongside standard care.
What this does not show
Only 58% adequately adhered. A prespecified 4–6-month analysis found lower ongoing pregnancy with the supplement, which is concerning but not a universal all-antioxidant harm estimate.
Exact ingredient
This is the tested Impryl combination; individual nutrients and other antioxidant blends are not equivalent treatments.
Why we included it
A recent large trial measured pregnancy rather than only sperm markers.
Related material only
These are different ingredients or forms. Do not assume the same findings apply to them.
No-benefit evidence reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.
Folic acid and elemental zinc
Form
Quality-controlled combination tablet; zinc salt not specified in the main report
How it is used
oral
Evidence
Large negative randomized trial
A large trial found no improvement in live birth or conventional semen measures. Live birth occurred in 34% of the supplement group and 35% of the placebo group.
Condition and setting
Couples undergoing infertility treatment; semen quality and live birth
Cautions
Digestive symptoms were more frequent, and sperm DNA fragmentation was slightly higher, although its clinical importance is uncertain. Avoid overlapping supplements; excessive zinc can cause copper deficiency.
Why no exact ingredient link?
A combination-tablet result cannot be assigned to folate or zinc as an individual treatment.
Evidence, limits and sources for Folic acid and zinc combination
What was found
FAZST: 2,370 couples; male partners took folic acid 5 mg plus elemental zinc 30 mg daily, or placebo, for six months.
What this does not show
Broad infertility-care population; six-month semen samples missing for 31%. Findings concern the combination and do not resolve treatment of a diagnosed deficiency or either nutrient alone.
Exact ingredient
This study tested the two nutrients together; neither ingredient alone represents the studied treatment.
Why we included it
Direct live-birth evidence from a large, blinded trial is more informative than semen-marker claims alone.
Related material only
These are different ingredients or forms. Do not assume the same findings apply to them.
Ingredient reference illustration: Selenium. Studied form: High-selenium yeast in the 2009 trial; selenomethionine in the older low-selenium study. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.
Selenium in specified supplement formulations
Form
High-selenium yeast in the 2009 trial; selenomethionine in the older low-selenium study
How it is used
oral
Evidence
Mixed and population-dependent trial evidence
Routine selenium supplementation is not supported for improving sperm quality. A small low-selenium study suggested benefit, but a longer trial in healthy men found none.
Condition and setting
Semen quality in healthy men and subfertile men with low selenium status
Cautions
Excess selenium can cause hair and nail loss, digestive symptoms and neurological problems. Correcting a diagnosed deficiency differs from routinely taking a high-dose fertility supplement.
2009: 54 randomized, 42 completed; selenium yeast 300 micrograms/day for 48 weeks, with no sperm benefit. 1998: 69 men with low selenium status; three-month trial.
What this does not show
The older motility result became significant only after pooling two selenium arms; five paternity events are too few for a firm fertility conclusion. A separate widely cited selenium/NAC trial has an Expression of Concern.
Exact ingredient
The studies used different selenium formulations and populations; high-selenium yeast and selenomethionine results are not automatically equivalent.
Why we included it
Separates nutrient sufficiency from unproven routine supplementation and preserves the important null result.